Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Our U.S. Offices Are Closed

Our U.S. offices are closed in observance of Memorial Day. We will reopen on Tuesday, May 31st.

Thank you for your patience.

To Purchase # 8230SC

8230SC 10 µg (With Carrier) $199.00
8230SF 10 µg (Carrier Free) $199.00
8230LC 50 µg (With Carrier) $599.00
8230LF 50 µg (Carrier Free) $599.00
$0.00

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

Source / Purification

Recombinant human LT-α (hLT-α) Pro36-Leu205 (Accession #NP_000586) was expressed in human 293 cells at Cell Signaling Technology.

Product Description

Purity:

>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hLT-α. All lots are greater than 98% pure.


Molecular Formula:

Recombinant hLT-α contains no "tags" and the nonglycosylated protein has a calculated MW of 18,548. DTT-reduced and non-reduced protein migrate as 24-31 kDa polypeptides. Lower mobility and heterogeneity in SDS-PAGE are due to glycosylation. The expected amino-terminal PGVGL of recombinant hLT-α was verified by amino acid sequencing.


Bioactivity:

The bioactivity of recombinant hLT-α was determined in an L-929 cell viability assay. The ED50 of each lot is between 15-150 pg/ml.


Endotoxin:

Less than 0.01 ng endotoxin/1 μg hLT-α.


Product Usage Information

Formulation:

With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg hLT-α. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2.


Storage: Stable in lyophilized state at 4°C for 1 year after receipt. Sterile stock solutions reconstituted with carrier protein are stable at 4°C for 2 months and at -20°C for 6 months. Avoid repeated freeze-thaw cycles.Maintain sterility. Storage at -20°C should be in a manual defrost freezer.

Lymphotoxin-α (LT-α), also known as TNF–β, is a member of the TNF superfamily of proteins (1). NK cells, T cells, B cells, and lymphoid tissue-inducer cells express LT-α (1). LT-α can be secreted as a soluble homotrimer or form membrane bound heterotrimers with lymphotoxin-β (LT α1β2 or LT α2β1) which can be cleaved from the cell surface by matrix metalloproteases (1,2). Soluble LT-α binds to and signals through TNFR1/TNFR2, activating the canonical NF-κB pathway (1). In contrast, LT α1β2 heterodimers bind to the LTβR receptor and activate the noncanonical NF-κB pathway (1). As a result, LT-α and TNF-α have overlapping functions. Soluble LT-α and LT α1β2 play key roles in lymphangiogenesis (3). The LT α1β2/LTβR axis is essential for the development of lymphoid tissue (1,3).


1.  Wolf, M.J. et al. (2010) Oncogene 29, 5006-18.

2.  Young, J. et al. (2010) Cytokine 51, 78-86.

3.  Mounzer, R.H. et al. (2010) Blood 116, 2173-82.


Entrez-Gene Id 4049
Swiss-Prot Acc. P01374


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

8230
Human Lymphotoxin-α/TNF-β/TNFSF1 (hLT-α)